Macular degeneration has a strong hereditary component. Twin studies estimate that genetics account for 46% to 71% of the variation in who develops the disease, with early forms at the lower end and advanced forms at the higher end. If your parent or sibling has age-related macular degeneration (AMD), your risk is roughly 12 times higher than someone without that family history.
That said, AMD isn’t caused by a single gene you either inherit or don’t. It’s a polygenic condition, meaning dozens of genetic variants each nudge your risk up or down, and lifestyle factors like smoking and diet interact with those variants in meaningful ways.
How Family History Affects Your Risk
The clearest evidence comes from sibling studies. Having a brother or sister with AMD is associated with a 12-fold increase in risk, with about 23% of siblings of affected individuals developing advanced forms of the disease. That’s a substantial jump compared to the general population, where overall prevalence in people over 50 is in the single digits.
This doesn’t mean you’ll inevitably develop AMD if it runs in your family. It means your baseline risk is significantly elevated, and the earlier you start paying attention to eye health and modifiable risk factors, the better positioned you are.
The Genetics Behind AMD
Researchers have identified more than 40 genes and genetic regions linked to AMD susceptibility. Two stand out as the most influential.
The first involves a gene that helps regulate your immune system’s complement cascade, a process your body uses to fight infection and clear damaged cells. In people with certain variants of this gene, the system doesn’t shut off properly. Inflammatory proteins accumulate in the retina over time, damaging the layer of tissue beneath it that keeps light-sensing cells healthy.
The second major risk gene appears to affect how cells in the retina handle stress and maintain their energy supply, though its exact mechanism is still being studied. Variants in this gene independently raise AMD risk, and carrying high-risk versions of both genes compounds the effect.
Together, these known genetic variants explain roughly half of the total heritability of AMD. The remaining genetic risk likely comes from combinations of smaller-effect variants that haven’t been fully characterized yet.
Genetic Risk Varies by Ethnicity
The frequency of high-risk gene variants differs significantly across racial and ethnic groups, which partly explains differences in AMD rates. In a large multi-ethnic U.S. study, researchers found striking variation in the distribution of the two most important risk genes.
For the complement-related gene variant, the high-risk version was most common in white and Black participants, less common in Hispanic participants, and rare in Chinese American participants (only 0.2% carried two copies compared to nearly 13% of white participants). But Chinese Americans carried higher frequencies of risk variants in other AMD-associated genes, which may explain why their rates of early AMD were similar to those seen in white participants.
Black participants had lower overall AMD incidence than white participants, attributed in part to differences in both protective and harmful gene variants. In a separate study of Mexican Americans, only 3% were homozygous for the main complement risk variant, compared to 9% to 21% of white populations, which correlated with lower rates of late-stage disease.
The takeaway: family history matters across all ethnic groups, but the specific genetic profile driving risk can look quite different depending on your ancestry.
Smoking and Genetics Amplify Each Other
Smoking is the single most important modifiable risk factor for AMD, and it doesn’t just add to genetic risk. It multiplies it. A large study following over 330,000 participants for an average of 13.6 years found a statistically significant synergistic interaction between a person’s overall genetic risk score and smoking history. The interaction was especially pronounced at the complement-related gene locations, which makes biological sense: smoking floods the retina with free radicals and toxic compounds that trigger the same inflammatory pathways those gene variants already struggle to regulate.
Current smoking is associated with approximately 45% increased odds of developing early AMD or seeing existing AMD progress over a 15-year period. For someone who already carries high-risk gene variants, that percentage likely underestimates the true combined effect.
What You Can Do With a Family History
Despite the strong genetic component, routine genetic testing for AMD is not currently recommended by the American Academy of Ophthalmology. The reason is practical: knowing your specific gene variants doesn’t yet change the treatment you’d receive. A major clinical trial found no significant difference in how patients responded to nutritional supplements based on their genetic profile. The supplements worked (or didn’t) regardless of genotype.
What does help is acting on the modifiable side of the equation, which is substantial given that 29% to 54% of AMD variation is driven by non-genetic factors.
- Don’t smoke. If you currently smoke, quitting is the single most protective step. Smoking concentrates toxic substances in the retina and directly accelerates the inflammatory damage that high-risk genes already predispose you to.
- Follow a Mediterranean-style diet. A prospective study found that strong adherence to a diet rich in leafy greens, colorful fruits and vegetables, legumes, whole grains, nuts, and fish lowers the risk of progressing to late-stage AMD.
- Stay physically active. A meta-analysis of over 38,000 people found that regular moderate exercise was associated with an 8% reduction in early AMD and a 41% reduction in late AMD, after controlling for age, sex, and smoking.
- Manage cardiovascular health. Diabetes, heart disease, hypertension, and obesity are all linked to AMD risk, likely because they share overlapping inflammatory and vascular pathways with retinal degeneration.
- Ask about AREDS2 supplements. For people who already have intermediate AMD, a specific combination of antioxidant vitamins and minerals has been shown to slow progression. These supplements are not recommended for people with only early-stage disease or no AMD at all.
How AMD Inheritance Differs From Single-Gene Diseases
If you’re used to thinking about hereditary conditions like sickle cell disease or cystic fibrosis, where one gene determines whether you get the condition, AMD works very differently. There’s no single mutation that causes it and no predictable inheritance pattern like “50% chance of passing it on.” Instead, each parent contributes a mosaic of risk variants, some protective and some harmful, and the combination you inherit interacts with decades of environmental exposures to determine your outcome.
This is why two siblings with the same parents can have very different outcomes. One might develop advanced AMD at 65 while the other has healthy retinas at 80. They share many of the same risk variants, but differences in diet, smoking history, cardiovascular health, and even sun exposure can tip the balance in opposite directions. A strong family history should prompt vigilance, not fatalism.